Browsing Centre for Immunobiology by Author "Abubakar, I"
Now showing items 1-18 of 18
-
Direct Whole-Genome Sequencing of Sputum Accurately Identifies Drug-Resistant Mycobacterium tuberculosis Faster than MGIT Culture Sequencing
Doyle, RM; Burgess, C; Williams, R; Gorton, R; Booth, H; Brown, J; Bryant, JM; Chan, J; Creer, D; Holdstock, J (2018-08) -
ERS/ECDC Statement: European Union standards for tuberculosis care, 2017 update
Migliori, GB; Sotgiu, G; Rosales-Klintz, S; Centis, R; D'Ambrosio, L; Abubakar, I; Bothamley, G; Antonio Caminero, J; Cirillo, DM; Dara, M (2018-05-01) -
Evaluation of QuantiFERON-TB Gold Plus for Predicting Incident Tuberculosis among Recent Contacts: A Prospective Cohort Study.
Gupta, RK; Kunst, H; Lipman, M; Noursadeghi, M; Jackson, C; Southern, J; Imran, A; Lozewicz, S; Abubakar, I (American Thoracic Society, 2020-02-21) -
Exploring a combined biomarker for tuberculosis treatment response: protocol for a prospective observational cohort study.
Kloprogge, F; Abubakar, I; Esmail, H; Hack, V; Kunst, H; McHugh, TD; Noursadeghi, M; Surey, J; Tiberi, S; Lipman, M (BMJ, 2021-07-08)INTRODUCTION: An improved understanding of factors explaining tuberculosis (TB) treatment response is urgently needed to help clinicians optimise and personalise treatment and assist scientists undertaking novel treatment ... -
A feasibility study evaluating the uptake, effectiveness and acceptability of routine screening of pregnant migrants for latent tuberculosis infection in antenatal care: a research protocol
Rahman, A; Thangaratinam, S; Copas, A; Zenner, D; White, PJ; Griffiths, C; Abubakar, I; McCourt, C; Kunst, H (2022) -
Fluoroquinolones and isoniazid-resistant tuberculosis: implications for the 2018 WHO guidance
Stagg, HR; Bothamley, GH; Davidson, JA; Kunst, H; Lalor, MK; Lipman, MC; Loutet, MG; Lozewicz, S; Mohiyuddin, T; Abbara, A (2019-10-01) -
Health and illness beliefs in adults with tuberculosis infection during the COVID-19 pandemic in the UK
Kılıç, A; Clarke, AL; Moon, Z; Hamada, Y; Chan, AHY; Rahman, A; Layton, C; Griffiths, CJ; Zenner, D; Powell, E (2024-06-01)Background: COVID-19 disrupted the TB prevention programme in the UK, especially for TB infection (TBI) care. We explore whether experience of the COVID-19 pandemic impacted on patients' perceptions of TBI and its treatment. ... -
IMPACT study on intervening with a manualised package to achieve treatment adherence in people with tuberculosis: protocol paper for a mixed-methods study, including a pilot randomised controlled trial
Stagg, HR; Abubakar, I; Campbell, CNJ; Copas, A; Darvell, M; Horne, R; Kielmann, K; Kunst, H; Mandelbaum, M; Pickett, E (2019-12) -
The Impact Study: A Cluster-randomised Clinical and Health Economic Feasibility Study of a Theory-based Manualised Intervention to Support People With Tuberculosis Disease During Treatment
Lipman, MC; Walker, E; Moon, Z; Weng, J; Abubakar, I; Campbell, C; Clarke, C; Copas, A; Costello, P; Darvell, M (2023) -
Improving engagement with healthcare in hepatitis C: a randomised controlled trial of a peer support intervention
Stagg, HR; Surey, J; Francis, M; MacLellan, J; Foster, GR; Charlett, A; Abubakar, I (2019-04-01) -
Is the Treatment of Latent Tuberculosis Infection Amongst Recent Migrants Safe and Effective in Primary Care?
Burman, M; Zenner, D; Copas, A; Gosce, L; White, P; Hickson, V; Greyson, O; Trathen, D; Ashcroft, R; Martineau, A (2021) -
IS THE TREATMENT OF LATENT TUBERCULOSIS INFECTION AMONGST RECENT MIGRANTS SAFE AND EFFECTIVE IN PRIMARY CARE?
Burman, M; Zenner, D; Copas, A; Gosce, L; Haghparast-Bidgoli, H; White, P; Hickson, V; Greyson, O; Trathen, D; Ashcroft, R (2021) -
An open label, randomised controlled trial of rifapentine versus rifampicin based short course regimens for the treatment of latent tuberculosis in England: the HALT LTBI pilot study.
Surey, J; Stagg, HR; Yates, TA; Lipman, M; White, PJ; Charlett, A; Muñoz, L; Gosce, L; Rangaka, MX; Francis, M (BioMed Central, 2021-01-21)BACKGROUND: Ending the global tuberculosis (TB) epidemic requires a focus on treating individuals with latent TB infection (LTBI) to prevent future cases. Promising trials of shorter regimens have shown them to be effective ... -
Quantitative Interferon Gamma Release Assay and Tuberculin Skin Test Results to Predict Incident Tuberculosis: A Prospective Cohort Study.
Gupta, RK; Lipman, M; Jackson, C; Sitch, A; Southern, J; Drobniewski, F; Deeks, JJ; Tsou, C-Y; Griffiths, C; Davidson, J (2019-12-11)RATIONALE: Development of diagnostic tools with improved predictive value for tuberculosis (TB) is a global research priority. OBJECTIVES: We evaluated whether implementing higher diagnostic thresholds than currently ... -
Randomised controlled trial to evaluate the effectiveness of using the RD-1-based C-Tb skin test as a replacement for blood-based interferon-gamma release assay for detection of, and initiation of preventive treatment for, tuberculosis infection: RID-TB:Dx study protocol
Rangaka, MX; Hamada, Y; Duong, T; Bern, H; Calvert, J; Francis, M; Clarke, AL; Ghanouni, A; Hack, V; Owen-Powell, E (2021) -
The Role of the Interferon Gamma Release Assay in Assessing Recent Tuberculosis Transmission in a Hospital Incident
Bradshaw, L; Davies, E; Devine, M; Flanagan, P; Kelly, P; O'Connor, K; Drobniewski, F; Nikolayevskyy, V; Abubakar, I (2011-06-13) -
Screening for tuberculosis among high-risk groups attending London Emergency Departments: A prospective observational study.
Gupta, RK; Lule, SA; Krutikov, M; Gosce, L; Green, N; Southern, J; Imran, A; Aldridge, RW; Kunst, H; Lipman, M (European Respiratory Society, 2021-03-18) -
“You have to change your whole life”: a qualitative study of the dynamics of treatment adherence among adults with tuberculosis in the United Kingdom
Karat, AS; Jones, AS; Abubakar, I; Campbell, CN; Clarke, AL; Clarke, CS; Darvell, M; Hill, AT; Horne, R; Kunst, H (2021-03-01)